- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +32 more
- Locations
-
Not specified
Clinical trial condition
Spondylitis, Ankylosing
Explore clinical trials studying Spondylitis, Ankylosing. Study availability and eligibility vary by location and protocol.
389 public trials
47 recruiting studies
Spondylitis, Ankylosing trial results
NCT01649375
- Conditions
- Anklyosing Spondylitis, Ankylosis, Arthritis, +9 more
- Locations
-
- Novartis Investigative Site Mesa, Arizona, United States
- Novartis Investigative Site Upland, California, United States
- Novartis Investigative Site Edina, Minnesota, United States
- Novartis Investigative Site Tupelo, Mississippi, United States
NCT04135508
- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
- Locations
-
Not specified
NCT02697968
- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
- Locations
-
- The University of Hong Kong Hong Kong
Completed
Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis
NCT02750592
- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
- Locations
-
- Novartis Investigative Site Kitakyushu, Fukuoka, Japan
- Novartis Investigative Site Kita-gun, Kagawa-ken, Japan
- Novartis Investigative Site Nankoku, Kochi, Japan
- Novartis Investigative Site Tenri, Nara, Japan
NCT03411798
- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +9 more
- Locations
-
- Nanfang Hospital Guangzhou, Guangdong, China
NCT01863732
- Conditions
- Ankylosis, Arthritis, Axial Spondyloarthritis, +8 more
- Locations
-
- Novartis Investigative Site Portland, Oregon, United States
- Novartis Investigative Site Duncansville, Pennsylvania, United States
- Novartis Investigative Site Jackson, Tennessee, United States
- Novartis Investigative Site Kingsport, Tennessee, United States
NCT01078558
- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +21 more
- Locations
-
Not specified
NCT02019602
- Conditions
- Ankylosing Spondylitis, Ankylosis, Arthritis, +30 more
- Locations
-
- 11 Scottsdale, Arizona, United States
- 9 Oklahoma City, Oklahoma, United States
- 101 Salt Lake City, Utah, United States
- 203 Lille, France
Completed
BI 655066 (Risankizumab) Proof of Concept Dose Finding Study in Ankylosing Spondylitis (AS)
NCT02047110
- Conditions
- Ankylosing Spondylitis (AS), Ankylosis, Arthritis, +9 more
- Locations
-
Not specified